Allogeneic HCT remains the only potentially curative treatment for myelodysplastic syndromes. This updated Brazilian consensus highlights advances in molecular risk assessment, patient selection, and donor choice to guide clinical decisions. doi.org/10.46765/267... #MedSky #HemeOnc #HemeSky #JBMTCT
